|
ZNF792 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.83310000406922E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76419989728061E-11 |
| Normal-vs-Stage2 |
4.430200E-02 |
| Normal-vs-Stage3 |
1.604460E-02 |
| Normal-vs-Stage4 |
3.997200E-01 |
| Stage1-vs-Stage2 |
3.587700E-02 |
| Stage1-vs-Stage3 |
1.398470E-04 |
| Stage1-vs-Stage4 |
1.94819999999041E-06 |
| Stage2-vs-Stage3 |
6.931200E-01 |
| Stage2-vs-Stage4 |
1.928840E-01 |
| Stage3-vs-Stage4 |
2.274000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.50870000223702E-08 |
| Normal-vs-AfricanAmerican |
4.292400E-02 |
| Normal-vs-Asian |
1.514620E-01 |
| Caucasian-vs-AfricanAmerican |
7.081800E-01 |
| Caucasian-vs-Asian |
4.550800E-01 |
| AfricanAmerican-vs-Asian |
4.709800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.03410000024718E-07 |
| Normal-vs-Female |
2.7953000000247E-06 |
| Male-vs-Female |
6.925200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.326070E-02 |
| Normal-vs-Age(41-60Yrs) |
6.17700000038468E-08 |
| Normal-vs-Age(61-80Yrs) |
5.60869999999269E-05 |
| Normal-vs-Age(81-100Yrs) |
8.776000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.558000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.204800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.203900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.134200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.455600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.230970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.755800E-03 |
| Normal-vs-Grade 2 |
8.52280468421895E-11 |
| Normal-vs-Grade 3 |
3.384200E-04 |
| Normal-vs-Grade 4 |
7.138600E-01 |
| Grade 1-vs-Grade 2 |
4.081800E-03 |
| Grade 1-vs-Grade 3 |
1.192380E-02 |
| Grade 1-vs-Grade 4 |
2.260800E-03 |
| Grade 2-vs-Grade 3 |
1.157260E-03 |
| Grade 2-vs-Grade 4 |
4.74579999742986E-08 |
| Grade 3-vs-Grade 4 |
2.638000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.25874874359988E-12 |
| Normal-vs-ccB subtype |
9.415900E-03 |
| ccA subtype-vs-ccB subtype |
4.35309999999856E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71501999999268E-05 |
| Normal-vs-N1 |
7.094200E-01 |
| N0-vs-N1 |
2.397200E-01 |
|
|
